Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Docetaxel and Cisplatin in Stage IIIA NSCLC (SAKK 16/96)
NCT00003231Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Apr 1997
- Primary completion
- Sep 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by Swiss Group for Clinical Cancer Research. Started Apr 1997; status: completed.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00003231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003231.